Flagship Harbor Advisors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.23M | Buy |
28,728
+4,561
| +19% | +$248K | 0.05% | 307 |
|
|
2026
Q1 | $1.52M | Buy |
24,167
+8,540
| +55% | +$683K | 0.07% | 244 |
|
|
2025
Q4 | $1.49M | Sell |
15,627
-5,157
| -25% | -$506K | 0.07% | 235 |
|
|
2025
Q3 | $2.03M | Buy |
20,784
+39
| +0.2% | +$4.04K | 0.09% | 199 |
|
|
2025
Q2 | $2.23M | Sell |
20,745
-391
| -2% | -$39.6K | 0.11% | 186 |
|
|
2025
Q1 | $2.13M | Buy |
21,136
+160
| +0.8% | +$16.1K | 0.11% | 166 |
|
|
2024
Q4 | $1.87M | Sell |
20,976
-162
| -0.8% | -$14.3K | 0.1% | 185 |
|
|
2024
Q3 | $1.77M | Buy |
21,138
+625
| +3% | +$49.3K | 0.1% | 197 |
|
|
2024
Q2 | $1.58M | Buy |
20,513
+27
| +0.1% | +$1.98K | 0.1% | 201 |
|
|
2024
Q1 | $1.4M | Buy |
20,486
+594
| +3% | +$38.2K | 0.09% | 203 |
|
|
2023
Q4 | $1.15M | Sell |
19,892
-50
| -0.3% | -$2.67K | 0.08% | 212 |
|
|
2023
Q3 | $1.05M | Buy |
19,942
+35
| +0.2% | +$1.84K | 0.09% | 207 |
|
|
2023
Q2 | $1.08M | Sell |
19,907
-561
| -3% | -$29.3K | 0.09% | 208 |
|
|
2023
Q1 | $1.02M | Buy |
20,468
+1,527
| +8% | +$72K | 0.1% | 213 |
|
|
2022
Q4 | $876K | Buy |
18,941
+350
| +2% | +$15.2K | 0.09% | 232 |
|
|
2022
Q3 | $720K | Sell |
18,591
-270
| -1% | -$10.8K | 0.08% | 240 |
|
|
2022
Q2 | $703K | Hold |
18,861
| – | – | 0.08% | 264 |
|
|
2022
Q1 | $835K | Buy |
18,861
+666
| +4% | +$28.9K | 0.08% | 246 |
|
|
2021
Q4 | $773K | Sell |
18,195
-100
| -0.5% | -$4.2K | 0.07% | 275 |
|
|
2021
Q3 | $782K | Hold |
18,295
| – | – | 0.08% | 260 |
|
|
2021
Q2 | $782K | Sell |
18,295
-528
| -3% | -$22.2K | 0.08% | 261 |
|
|
2021
Q1 | $728K | Sell |
18,823
-192
| -1% | -$7.27K | 0.08% | 255 |
|
|
2020
Q4 | $684K | Buy |
19,015
+2,535
| +15% | +$91.4K | 0.08% | 241 |
|
|
2020
Q3 | $629K | Sell |
16,480
-676
| -4% | -$26K | 0.08% | 224 |
|
|
2020
Q2 | $602K | Sell |
17,156
-172
| -1% | -$6.19K | 0.09% | 224 |
|
|
2020
Q1 | $565K | Buy |
17,328
+177
| +1% | +$6.92K | 0.11% | 175 |
|
|
2019
Q4 | $776K | Sell |
17,151
-557
| -3% | -$23.3K | 0.14% | 156 |
|
|
2019
Q3 | $720K | Sell |
17,708
-1,450
| -8% | -$61.4K | 0.14% | 153 |
|
|
2019
Q2 | $823K | Sell |
19,158
-1,740
| -8% | -$66.9K | 0.17% | 134 |
|
|
2019
Q1 | $802K | Buy |
20,898
+2,830
| +16% | +$108K | 0.16% | 133 |
|
|
2018
Q4 | $638K | Buy |
18,068
+2,525
| +16% | +$91.6K | 0.16% | 146 |
|
|
2018
Q3 | $606K | Hold |
15,543
| – | – | 0.11% | 191 |
|
|
2018
Q2 | $508K | Sell |
15,543
-231
| -1% | -$6.97K | 0.1% | 213 |
|
|
2018
Q1 | $423K | Sell |
15,774
-375
| -2% | -$10.2K | 0.13% | 197 |
|
|
2017
Q4 | $418K | Sell |
16,149
-2,732
| -14% | -$75.4K | 0.12% | 197 |
|
|
2017
Q3 | $552K | Buy |
18,881
+282
| +2% | +$7.79K | 0.18% | 149 |
|
|
2017
Q2 | $514K | Buy |
18,599
+2,333
| +14% | +$61.9K | 0.18% | 151 |
|
|
2017
Q1 | $397K | Buy |
+16,266
| New | +$396K | 0.15% | 170 |
|
Other funds holding BSX
Flagship Harbor Advisors's BSX Position: Q2 2026 in Review
Flagship Harbor Advisors increased its Boston Scientific (BSX) stake by 19% in Q2 2026, buying an estimated $248K and bringing the position to 28,728 shares worth $1.23M. The position accounts for 0.05% of the portfolio, ranked #307.
Flagship Harbor Advisors first reported a position in BSX in Q1 2017 and has held it in 38 quarters since. The position peaked at $2.23M in Q2 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Flagship Harbor Advisors held 28,728 shares of Boston Scientific worth $1.23M as of Q2 2026.
- Flagship Harbor Advisors bought 4,561 Boston Scientific shares in Q2 2026, an estimated $248K.
- Boston Scientific made up 0.05% of Flagship Harbor Advisors's portfolio in Q2 2026, its #307 holding.
- Flagship Harbor Advisors first reported a position in Boston Scientific in Q1 2017 and has held it in 38 quarters since.
- Flagship Harbor Advisors's Boston Scientific position peaked at $2.23M in Q2 2025.
- 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Flagship Harbor Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.